Adipocyte Hypoxia-Inducible Factor 2α Suppresses Atherosclerosis by Promoting Adipose Ceramide Catabolism

  • Cell Metab. 2019 Nov 5;30(5):937-951.e5. doi: 10.1016/j.cmet.2019.09.016.
Xingzhong Zhang  1 Yangming Zhang  1 Pengcheng Wang  1 Song-Yang Zhang  1 Yongqiang Dong  1 Guangyi Zeng  1 Yu Yan  1 Lulu Sun  1 Qing Wu  1 Huiying Liu  1 Bo Liu  1 Wei Kong  1 Xian Wang  1 Changtao Jiang  2
Affiliations
  • 1. Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing 100191, PRC; Center for Obesity and Metabolic Disease Research, School of Basic Medical Sciences, Peking University, Beijing 100191, PRC.
  • 2. Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing 100191, PRC; Center for Obesity and Metabolic Disease Research, School of Basic Medical Sciences, Peking University, Beijing 100191, PRC. Electronic address: [email protected].
Abstract

Obesity-induced adipose dysfunction is a major contributor to atherosclerosis. Cold exposure has been reported to affect atherosclerosis through regulation of adipose function, but the mechanism has not been well clarified. Here, adipocyte hypoxia-inducible factor 2α (HIF-2α) was upregulated after mild cold exposure at 16°C and mediated cold-induced thermogenesis. Adipocyte HIF-2α deficiency exacerbated Western-diet-induced atherosclerosis by increasing adipose ceramide levels, which blunted hepatocyte Cholesterol elimination and thermogenesis. Mechanistically, Acer2, the gene encoding alkaline Ceramidase 2, was identified as a novel target gene of HIF-2α, triggering ceramide catabolism. Adipose overexpression of ACER2 rescued adipocyte HIF-2α-deficiency-induced exacerbation of atherosclerosis. Furthermore, activation of adipose HIF-2α by the HIF prolyl hydroxylase inhibitor FG-4592 had protective effects on atherosclerosis, accompanied by a reduction in adipose and plasma ceramide and plasma Cholesterol levels. This study highlights adipocyte HIF-2α as a putative drug target against atherosclerosis.

Keywords
HIF-2α; adipocyte; atherosclerosis; ceramide.
Products